Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
14.40
+0.13 (0.91%)
Mar 6, 2026, 4:00 PM EST - Market closed
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
$138,387
Profits / Employee
$22,644
Market Cap
11.81B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | 22,739 | 1,089 | 5.03% |
| Mar 31, 2020 | 21,650 | -316 | -1.44% |
| Mar 31, 2019 | 21,966 | -1,558 | -6.62% |
| Mar 31, 2018 | 23,524 | 853 | 3.76% |
| Mar 31, 2017 | 22,671 | 496 | 2.24% |
| Mar 31, 2016 | 22,175 | 1,802 | 8.85% |
| Mar 31, 2015 | 20,373 | 1,952 | 10.60% |
| Mar 31, 2014 | 18,421 | 1,804 | 10.86% |
| Mar 31, 2013 | 16,617 | 1,417 | 9.32% |
| Mar 31, 2012 | 15,200 | 277 | 1.86% |
| Mar 31, 2011 | 14,923 | 1,468 | 10.91% |
| Mar 31, 2010 | 13,455 | 2,227 | 19.83% |
| Mar 31, 2009 | 11,228 | 1,653 | 17.26% |
| Mar 31, 2008 | 9,575 | 555 | 6.15% |
| Mar 31, 2007 | 9,020 | 1,495 | 19.87% |
| Mar 31, 2006 | 7,525 | 1,390 | 22.66% |
| Mar 31, 2005 | 6,135 | -20 | -0.32% |
| Mar 31, 2004 | 6,155 | 303 | 5.18% |
| Mar 31, 2003 | 5,852 | 409 | 7.51% |
| Mar 31, 2002 | 5,443 | 314 | 6.12% |
| Mar 31, 2001 | 5,129 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 30,000 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,300 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| United Therapeutics | 1,400 |
RDY News
- 1 day ago - Top stocks to watch today, March 6: TCS, Tata Elxsi, GE Shipping, GRSE, Dr Reddy’s Lab, Mazagon Dock, Wipro, Bharat Forge, Angel One in focus - Business Upturn
- 2 days ago - Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's - Nasdaq
- 8 days ago - Top losers among Nifty 50 stocks in midday trades today, Feb 27: Dr. Reddy’s falls 2.8%, Bharti Airtel down 2.7%, Grasim Industries drops 2.5% - Business Upturn
- 8 days ago - Pharma sector stocks today, Feb 27: Dr. Reddys Lab down 1.14%, Cipla falls 1.04%, Natco Pharma up 1.09% - Business Upturn
- 10 days ago - Citi flags Ozempic price cuts as negative for Dr Reddy’s generic Semaglutide uptake - Business Upturn
- 15 days ago - Dr. Reddy's (RDY) Biosimilar Application for Orencia Accepted by FDA - GuruFocus
- 15 days ago - Dr. Reddy's Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept - Business Wire
- 17 days ago - Dr. Reddy’s Laboratories acquires Progynova and Cyclo-Progynova trademarks in India for $32.15 million - Business Upturn